Return to search results.
Complete title: Cellular Proliferation Imaging Using [18F]fluorothymidine (FLT) Positron Emission Tomography (PET) in Brain Tumors
|Research Study Number||7754|
|Principal Investigator||Jason Rockhill|
Research Study Description
Eligibility Criteria (must meet the following to participate in this study)
Genders Eligible for Study: Both
- Have a diagnosis of malignant brain tumor (primary, recurrent, or metastatic) by standard clinical-pathological diagnosis
- Planned for treatment with radiation, chemotherapy and surgical resection or any of these treatment strategies combined
Other eligibility criteria may apply.
Exclusions (conditions that would prevent participation in this study)
- Inability to lie still for the imaging study
- Weight over 350 lbs.
Other exclusion criteria may apply.
Brain Cancer; Central Nervous System (CNS); Solid Tumors
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.